In this study, we measured apoA-I glycation level and serum and HDL-associated activities of PON1 and PON3, to test the hypothesis that elevated apoA-I glycation and reduced PON1 and PON3 activities and their interaction were related to the presence and severity of CAD in patients with T2DM. The gene discussed is PON3; the disease is coronary artery disorder.